Example: Heart Attack

Search clinical trials for: Hemagglutinins

Total 144 results

NCT03038776

Completed

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Conditions: Influenza, Avian
NCT00328107

Completed

Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults

Conditions: Influenza
NCT00539981

Completed

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Conditions: Influenza
NCT03460743

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Conditions: Influenza, Human
NCT00336453

Completed

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Conditions: Influenza
NCT00517517

Completed

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Conditions: Influenza
NCT00783926

Completed

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Conditions: Influenza; Pandemic Influenza
NCT01147068

Completed

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

Conditions: Influenza
NCT04077424

Completed

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Conditions: Flu Vaccine
NCT00395174

Completed

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

Conditions: Influenza
NCT02335164

Completed

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Conditions: Influenza
NCT02015494

Unknown status

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Conditions: Influenza
NCT02434276

Unknown status

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Conditions: Influenza
NCT02464163

Completed

Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older

Conditions: Influenza
NCT01612000

Completed

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

Conditions: Influenza
NCT01971255

Completed

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People

Conditions: Influenza
NCT02511002

Recruiting

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Conditions: Post Influenza
NCT04024228

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Conditions: Influenza (Healthy Volunteers)
NCT01229371

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Conditions: Influenza
NCT00489931

Completed

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Conditions: Influenza A Virus, H5N1 Subtype; Influenza A Virus; Influenzavirus A; Orthomyxovirdae; H5N1 Virus
NCT02247362

Unknown status

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Conditions: Influenza
NCT00539864

Completed

Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV

Conditions: Influenza
NCT03330132

Active, not recruiting

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong

Conditions: Influenza, Human
NCT02555618

Completed

Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants

Conditions: Influenza Infection
NCT01459666

Terminated

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

Conditions: Scar